Read an important notice regarding the data security incident McKesson reported on August 28, 2026. Read more.
< All Clinical Trials
Disease Type: Myelomas
Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma (OPTec/OPTal)
Roanoke